Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

4 articles from the last 90 days matching "Noma"

ResearchPUBMEDApr 29

Adenocarcinoma of the small intestine cohort: prospectively collecting real-world data to improve care and quality of life for patients with a rare cancer.

Researchers in the Netherlands are creating a large database to collect information about small intestinal adenocarcinoma, a rare type of cancer that starts in the small intestine. They're gathering medical records, tumor samples, and patient feedback to better understand how this cancer develops and which treatments work best. This study is important because doctors currently don't have enough information to know the best way to treat this disease.

WHY IT MATTERSFor the first time, patients with small intestinal adenocarcinoma will have their disease studied systematically in a large prospective cohort, which could lead to treatment recommendations tailored specifically to this rare cancer instead of borrowed from other gastrointestinal cancers.
ℹ Good to knowsmall intestinal adenocarcinomaadenocarcinoma of the small intestineRead →
ResearchPUBMEDMar 26

Primary Clear Cell Adenocarcinoma of the Female Urethra: A Case Report of a Rare Disease.

Doctors found a very rare type of cancer in a woman's urethra (the tube that carries urine out of the body). This cancer, called clear cell adenocarcinoma, is so uncommon that only a few cases have ever been reported. The article describes how doctors used special imaging scans (MRI and PET/CT) to find and diagnose this cancer.

WHY IT MATTERSThis case report helps doctors recognize and diagnose primary clear cell adenocarcinoma of the female urethra earlier, since it's so rare that many physicians may never encounter it in their careers.
ℹ Good to knowPrimary Clear Cell Adenocarcinoma of the Female UrethraUrethral NeoplasmsClear Cell AdenocarcinomaRead →
ResearchCLINICALTRIALSMar 26

Trial Completed: Evaluating an Artificial Intelligence Tool to Help Primary Care Doctors Diagnose Skin Conditions. (NCT07428941)

Researchers completed a study testing whether an artificial intelligence tool can help regular doctors better diagnose skin conditions. The AI was designed to reduce mistakes and unnecessary specialist referrals by giving primary care doctors better information about skin problems like melanoma, psoriasis, and other conditions. With only 9 participants, this was a small early-stage study to see if the technology works.

WHY IT MATTERSIf this AI tool works well, patients with rare skin conditions like hidradenitis suppurativa could get faster, more accurate diagnoses from their regular doctor instead of waiting for specialist appointments.
ℹ Good to knowMelanomaBasal Cell CarcinomaMelanocytic NeviRead →
ResearchCLINICALTRIALSMar 26

New Clinical Trial: Optimal Methods of Disease Progression and Survival Analysis in Children and Adults Patients With Adrenocortical Cancer (ACC) (NCT04358107)

Researchers are studying 1,000 children and adults with adrenocortical carcinoma (ACC), a rare cancer of the adrenal glands. They want to understand why some people survive longer than others and whether certain treatments work better. The average person with ACC lives about 14.5 months after diagnosis, but survival times vary widely.

WHY IT MATTERSThis study is actively collecting data that could help doctors better predict outcomes and choose more effective treatments for ACC patients, though it is not currently recruiting new participants.
💬 Ask your doctorAdrenocortical CarcinomaRead →

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases